Chimeric Therapeutics Stock Guidance | OTC:CHMMF | Benzinga

Chimeric Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Chimeric Therapeutics Ltd (CHMMF) does not provide guidance data

FAQ

Q

What is the most recent guidance for Chimeric Therapeutics (CHMMF)?

A

There have been no specific sales or earnings guidance reported for Chimeric Therapeutics in recent months.

Browse guidance and forecast on all stocks.